We are live on
!
Find out more
GF
Gray Foundation Portfolio holdings
AUM
$454M
1-Year Est. Return
38.19%
This Fund
S&P 500
This Quarter
Est. Return
+0.13%
1 Year Est. Return
+38.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$397M
AUM Growth
-$1.78M
(-0.45%)
Cap. Flow
-$193
Cap. Flow
% of AUM
-0%
Top 10 Holdings %
Top 10 Hldgs %
99.09%
Holding
11
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$193 |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 58.17% |
| 2 | Communication Services | 8.1% |
| 3 | Healthcare | 2.16% |
| 4 | Real Estate | 2.13% |
| 5 | Industrials | 1.32% |
Similar funds
EGP
HIM
OCM
AA
PC
FCMV
BI
RAA
Gray Foundation's Q1 2026 Portfolio in Review
As of Q1 2026, Gray Foundation held 11 positions worth $397M, down 0.45% from $399M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 0%. Gray Foundation opened no new positions and made no exits, leaving the 11-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 58% of assets, up from 55% a quarter earlier, followed by Communication Services and Healthcare.
- Gray Foundation's biggest Q1 2026 reduction was AstraZeneca, cutting an estimated $193.
- Gray Foundation's ten largest holdings make up 99% of its $397M portfolio in Q1 2026.
- Gray Foundation opened 0 new positions and closed 0 in Q1 2026.
- Gray Foundation's portfolio value fell 0.45% quarter-over-quarter to $397M.
Based on Gray Foundation's 13F filing for Q1 2026, filed 22 Apr 2026.